Gene therapy for primary immunodeficiencies. (2012)

First Author: Rivat C
Attributed to:  Development of a lentiviral vector for gene therapy of ADA deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/hum.2012.116

PubMed Identifier: 22691036

Publication URI: http://europepmc.org/abstract/MED/22691036

Type: Journal Article/Review

Volume: 23

Parent Publication: Human gene therapy

Issue: 7

ISSN: 1043-0342